Article Correctness Is Author's Responsibility: Discovery May Point to Parkinson’s Disease Therapies

The article below may contain offensive and/or incorrect content.

This shows a brainIn Parkinson's disease, alpha-synuclein binds to LC3B. Normally, LC3B causes misfolded proteins to become degraded, but in the case of Parkinson's, LC3B becomes trapped in protein aggregates and becomes inactive.